- Digital PCR
- NGS Content Enrichment
- News & Events
The ThunderBolts™ Cancer Panel is a comprehensive next-generation sequencing (NGS) panel for profiling important cancer mutations. The ThunderBolts Cancer Panel enables researchers to rapidly detect and cost-effectively analyze mutations on precious FFPE (Formalin-Fixed Paraffin-Embedded), tissue, and Fluid Biopsy™ samples (circulating tumor DNA or ctDNA). The ThunderBolts Cancer Panel uses single molecule PCR to target 50 known cancer genes including tumor suppressors, mutation hotspots and drug resistance markers. The panel also features industry breakthroughs in sequence coverage and uniformity, allelic sensitivity, sample flexibility, workflow, and cost.
The ThunderBolts Cancer Panel includes content found on the Ion Torrent AmpliSeq™ Cancer Hotspot Panel v2 and Illumina TruSeq® Amplicon Cancer Panel products. The ThunderBolts Panel also features several industry advantages:
The ThunderBolts Cancer Panel is currently being made available to select First Access Program (FAP) participants. Researchers from FAP sites presented data during the American Association for Cancer Research (AACR) Annual Meeting in April 2014 in San Diego, California. The workshop recording is available below:
The ThunderBolts Cancer Panel is for Research Use Only; not for use in diagnostic procedures.
RECEIVE EMAIL UPDATES:
LIVE TWITTER FEED
Check out today's exciting press release: RainDance Technologies Appoints Kathy Ordoñez to Board of Directors bit.ly/1r4oHt1